- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07635979
Physiological Responses to Upper Limb NMES
Exploring Local Physiological Changes in the Arm During NMES Using the Firefly® Device
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
Participants will undergo NMES using the Firefly® device, applied to two predefined regions of the upper limb: one targeting the anterior arm nerve bundle (a collective term referring to motor and sensory nerves within the anterior and medial compartments of the upper arm, including the musculocutaneous and adjacent (median, medial cutaneous, ulnar and radial) nerves, and the other targeting the median nerve in the proximal forearm.
Vascular responses will be assessed at two sites, the brachial artery and axillary vein, using Doppler ultrasound. For each nerve-vascular site pairing, NMES will alternate between stimulation OFF and ON conditions (10 OFF and 10 ON cycles), comprising one stimulation block of approximately 20 minutes. Each participant will complete four stimulation blocks in total.
During both ON and OFF phases, blood flow volume and haemodynamic parameters, including peak systolic velocity (PSV), end-diastolic velocity (EDV), and resistive index (RI), will be recorded. Additionally, local muscle oxygen saturation (SmO₂) will be continuously monitored using functional near-infrared spectroscopy (fNIRS) to assess tissue-level physiological changes.
The total study participation time per individual is approximately 2 hours.
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
Buckinghamshire
-
High Wycombe, Buckinghamshire, Det Forenede Kongerige, HP11 1JX
- Firstkind
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
- Voksen
Tager imod sunde frivillige
Beskrivelse
Inclusion Criteria:
- Aged 18 to 45 years (inclusive)
- No known history of vascular or neurological conditions affecting the upper extremities
- Able to read, understand, and communicate in English to ensure informed consent and safe participation in the study
Exclusion Criteria:
- Presence of any condition that contraindicates the use of neuromuscular electrical stimulation (e.g., implanted pacemaker, epilepsy)
- Current or recent injury to the upper limbs that may interfere with stimulation or measurement
- Anatomical variations in the brachial artery or axillary vein, specifically vascular branching outside expected anatomical locations, as identified by ultrasound, which may impair accurate blood flow measurement or device placement
- Currently participating in another interventional or physiological research study or having done so within the past 30 days.
- Currently pregnant
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Grundvidenskab
- Tildeling: N/A
- Interventionel model: Enkelt gruppeopgave
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Single experimental arm: Firefly NMES
|
Firefly NMES device applied to the upper limb during a single-visit exploratory pysiological study
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in upper-limb blood flow volume during NMES (ON vs OFF)
Tidsramme: During single study visit (approximately 2 hours), across repeated stimulation ON/OFF cycles
|
Within-subject change in upper-limb blood flow volume (mL/min) measured using Doppler ultrasound during neuromuscular electrical stimulation (NMES) delivered via the Firefly device, comparing stimulation ON versus OFF conditions.
Measurements will be collected across repeated stimulation cycles at predefined upper-limb stimulation zones and vascular assessment sites.
|
During single study visit (approximately 2 hours), across repeated stimulation ON/OFF cycles
|
|
Change in upper-limb peak systolic velocity during NMES (ON vs OFF)
Tidsramme: During a single study visit (approximately 2 hours), across repeated stimulation ON/OFF cycles.
|
Within-subject change in upper-limb peak systolic velocity (PSV; cm/s) measured using Doppler ultrasound during NMES delivered via the Firefly device, comparing stimulation ON versus OFF conditions across repeated stimulation cycles at predefined upper-limb stimulation zones and vascular assessment sites.
|
During a single study visit (approximately 2 hours), across repeated stimulation ON/OFF cycles.
|
|
Change in upper-limb end-diastolic velocity during NMES (ON vs OFF)
Tidsramme: During a single study visit (approximately 2 hours), across repeated stimulation ON/OFF cycles.
|
Within-subject change in upper-limb end-diastolic velocity (EDV; cm/s) measured using Doppler ultrasound during NMES delivered via the Firefly device, comparing stimulation ON versus OFF conditions across repeated stimulation cycles at predefined upper-limb stimulation zones and vascular assessment sites.
|
During a single study visit (approximately 2 hours), across repeated stimulation ON/OFF cycles.
|
|
Change in upper-limb resistive index during NMES (ON vs OFF)
Tidsramme: During a single study visit (approximately 2 hours), across repeated stimulation ON/OFF cycles.
|
Within-subject change in upper-limb resistive index (RI; unitless ratio) derived from Doppler ultrasound measurements during NMES delivered via the Firefly device, comparing stimulation ON versus OFF conditions across repeated stimulation cycles at predefined upper-limb stimulation zones and vascular assessment sites.
|
During a single study visit (approximately 2 hours), across repeated stimulation ON/OFF cycles.
|
|
Change in upper-limb muscle oxygen saturation during NMES (ON vs OFF)
Tidsramme: During a single study visit (approximately 2 hours), across repeated stimulation ON/OFF cycles.
|
Within-subject change in upper-limb muscle oxygen saturation (SmO₂; %) measured continuously using functional near-infrared spectroscopy (fNIRS) during NMES delivered via the Firefly device, comparing stimulation ON versus OFF conditions across repeated stimulation cycles at predefined upper-limb stimulation zones and assessment sites.
|
During a single study visit (approximately 2 hours), across repeated stimulation ON/OFF cycles.
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Incidence of adverse events and device-related effects
Tidsramme: During single study visit (approximately 2 hours)
|
Number and type of adverse events (AEs), serious adverse events (SAEs), adverse device effects (ADEs), serious adverse device effects (SADEs), and device deficiencies observed during study participation.
|
During single study visit (approximately 2 hours)
|
Samarbejdspartnere og efterforskere
Sponsor
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Andre undersøgelses-id-numre
- FFR-ARM-002 (Andet bevillings-/finansieringsnummer: Firstkind)
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
IPD-planbeskrivelse
IPD-deling Understøttende informationstype
- STUDY_PROTOCOL
- ICF
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
produkt fremstillet i og eksporteret fra U.S.A.
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Sunde voksne deltagere
-
Al-Azhar UniversityAfsluttetSucces med adult pulpotomi hos patienter med diabetesEgypten
-
Nanjing Medical UniversityRekrutteringAdult Attention Deficit Hyperactivity DisorderKina
-
Wolfson Medical CenterUkendt
-
Ethicon Endo-SurgeryAfsluttetPædiatriske procedurer | Adult Hepato-pancreato-biliær (HPB) procedurer | Voksen nedre gastrointestinale procedurer | Gastriske procedurer for voksne | Gynækologiske procedurer for voksne | Voksen urologiske procedurer | Voksen thoraxprocedurerForenede Stater, Canada, Det Forenede Kongerige
-
Novartis PharmaceuticalsAfsluttetAdult Debut Still's DiseaseJapan
-
AO GENERIUMAfsluttetStills Sygdom Adult DebutDen Russiske Føderation
-
AB2 Bio Ltd.AfsluttetStills sygdom, voksendebutTyskland, Frankrig, Schweiz
-
Rochester Center for Behavioral MedicineShireAfsluttetAdult Attention-Deficit Hyperactivity DisorderForenede Stater
-
Apollo Therapeutics LtdAfsluttetAdult Debut Still's DiseaseForenede Stater, Belgien, Polen, Ukraine
-
Tel-Aviv Sourasky Medical CenterElMindA Ltd; Brainsway; Ornim Medical Ltd.UkendtAdult Attention Deficit DisorderIsrael
Kliniske forsøg med Firefly NMES device
-
Hospital Universitário Professor Edgard SantosIkke rekrutterer endnuLevercirrhose | Sarkopeni
-
Hospital de Clinicas de Porto AlegreAfsluttetType 2 diabetes mellitusBrasilien
-
The Hong Kong Polytechnic UniversityUkendt
-
University Hospital, GenevaEcole Polytechnique Fédérale de Lausanne; Clinique Romande de ReadaptationAfsluttet
-
Bursa Yuksek Ihtisas Training and Research HospitalAfsluttetHemiplegi | Dysfunktion i øvre ekstremiteterTyrkiet (Türkiye)
-
Barts & The London NHS TrustAfsluttetBrud, lukket
-
University of MichiganSpring Arbor UniversityAfsluttet
-
Gulhane School of MedicineRekruttering
-
Istanbul Arel UniversityHacettepe University; Istinye UniversityTilmelding efter invitationSlag | Dysfagi | HemipareseTyrkiet (Türkiye)
-
Lawson Health Research InstituteCanadian Institutes of Health Research (CIHR); Western UniversityRekrutteringDistal Radius FrakturCanada